Max Robotics — Global Service Robot Directory + US Certification

About

Anna Herland is a pioneering figure in the field of organ-on-a-chip technology, with a research focus on creating advanced *in vitro* models that mimic human physiology for drug development. Her major contributions center on the development of fluidically coupled, multi-organ chip systems that can predict human pharmacokinetic responses more accurately than traditional methods. Her landmark 2020 paper on "Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips" (463 citations) demonstrated how linked organ chips can replicate complex drug metabolism and distribution. Complementing this, her work on "Robotic fluidic coupling and interrogation of multiple vascularized organ chips" (401 citations) introduced automated systems for high-throughput experimentation. Her 2019 paper detailing the "Interrogator" robotic platform—capable of automated culture, perfusion, and imaging of up to ten organ chips—showcases her innovative approach to scaling these technologies. With over 870 combined citations for her most influential works, Herland's research is driving a paradigm shift toward more predictive, human-relevant drug testing, reducing reliance on animal models and accelerating the path to clinical therapies.